CANTOURAGE GROUP SE O.N. (F:HIGH) — Market Cap & Net Worth
Market Cap & Net Worth: CANTOURAGE GROUP SE O.N. (HIGH)
CANTOURAGE GROUP SE O.N. (F:HIGH) has a market capitalization of $43.58 Million (€37.28 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #22504 globally and #1971 in its home market, demonstrating a -12.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CANTOURAGE GROUP SE O.N.'s stock price €5.16 by its total outstanding shares 11875000 (11.88 Million).
CANTOURAGE GROUP SE O.N. Market Cap History: 2022 to 2026
CANTOURAGE GROUP SE O.N.'s market capitalization history from 2022 to 2026. Data shows change from $192.42 Million to $71.64 Million (-24.26% CAGR).
CANTOURAGE GROUP SE O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CANTOURAGE GROUP SE O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest CANTOURAGE GROUP SE O.N. stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HIGH by Market Capitalization
Companies near CANTOURAGE GROUP SE O.N. in the global market cap rankings as of September 19, 2026.
Key companies related to CANTOURAGE GROUP SE O.N. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
CANTOURAGE GROUP SE O.N. Historical Marketcap From 2022 to 2026
Between 2022 and today, CANTOURAGE GROUP SE O.N.'s market cap moved from $192.42 Million to $ 71.64 Million, with a yearly change of -24.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €71.64 Million | +55.42% |
| 2025 | €46.09 Million | -33.06% |
| 2024 | €68.86 Million | -30.82% |
| 2023 | €99.54 Million | -48.27% |
| 2022 | €192.42 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of CANTOURAGE GROUP SE O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.58 Million USD |
| MoneyControl | $43.58 Million USD |
| MarketWatch | $43.58 Million USD |
| marketcap.company | $43.58 Million USD |
| Reuters | $43.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CANTOURAGE GROUP SE O.N.
Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.